• 1
    Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced size liver transplants as split grafts, auxiliary orthotopic grafts and living related segmental transplants. Ann Surg 1990; 212: 368377.
  • 2
    Broelsch CE, Whitington PF, Emond JC, Heffron TG, Thistlethwaite JR, Stevens L, Piper J, et al. Liver transplantation in children from living related donors: surgical techniques and results. Ann Surg 1991; 214: 428439.
  • 3
    Singer PA, Siegler M, Whitington PF, Lantos J, Emond JC, Thistlethwaite JR, Broelsch CE. Ethics of liver transplantation using living donors. N Engl J Med 1989; 321: 620622.
  • 4
    Ozawa K, Uemoto S, Tanaka K, Kumada K, Yamaoka Y, Kobayashi N, Inamoto T, et al. An appraisal of pediatric liver transplantation from living relatives. Initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors. Ann Surg 1992; 216: 547553.
  • 5
    Piper JB, Whitington PF, Woodle ES, Newell KA, Alonso EM, Emond JC, Heffron TG, et al. Pediatric liver transplantation at the University of Chicago Hospitals. In: TerasakiPI, CeckaJM, eds. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1992: 179189.
  • 6
    Emond JC. Clinical application of living-related liver transplantation. Gastroenterol Clin North Am 1993; 22: 301315.
  • 7
    Brady L, Gokhale R, Alonso EM, Whitington PF. Issues unique to pediatric patients undergoing liver transplantation. Semin Gastrointest Dis 1993; 4: 138150.
  • 8
    McEnery PT, Stablein DM, Arbus G, Tejani A. Renal transplantation in children. A report of the North American Pediatric Renal Transplant Cooperative Study. N Engl J Med 1992; 326: 17271732.
  • 9
    Emond JC, Thistlethwaite JR, Baker AL, Whitington PF, Ferrari M, Carmellini M, Stuart FP, et al. Rejection in liver allograft recipients: clinical characterization and management. Clin Transpl 1987; 1: 143150.
  • 10
    Alonso EM, Gonzalez-Vallina R, Whitington PF. Update of pediatric liver transplantation. Eur J Pediatr 1992; 151: S23S31.
  • 11
    Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 1987; 11: 110.
  • 12
    Aran PP, Bostwick DA, Bissell M, Ademac T, Whitington PF, Kane S, Baker AL. The clinical utility of liver biopsy in the diagnosis of post liver transplantation graft rejection. Clin Transpl 1994; 7: 475481.
  • 13
    Whittington PF, Balistreri WF. Liver transplantation in pediatrics: indications, contraindications, and pre-transplant management. J Pediatr 1991; 118: 169177.
  • 14
    Cecka JM, Terasaki PI. The UNOS Scientific Renal Transplant Registry. In: TerasakiPI, CeckaJM, eds. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1992: 116.
  • 15
    Koyama H, Cecka JM. Rejection episodes. In: TerasakiPI, CeckaJM, eds. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1992: 391404.
  • 16
    Vierling JM. Immunologic mechanisms of hepatic allograft rejection. Semin Liver Dis 1992; 12: 1627.
  • 17
    Fung JJ, Zeevi A, Starzl TE, Demetris J, Iwatsuki S, Duquesnoy RJ. Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol 1986; 16: 182199.
  • 18
    Markus GH, Duquesnoy RJ, Gordon RD, Fung JJ, Vanek M, Klintmalm G, Bryan C, et al. Histocompatability and liver transplant outcome. Transplantation 1988; 46: 372377.
  • 19
    Campbell DA Jr, Merion RM, Ham JM, Lucey MR, Henley KS, Turcotte G. Hepatic preservation with University of Wisconsin solution is associated with reduced allograft rejection. Transplant Proc 1991; 23: 15471549.
  • 20
    Howard TK, Klintmalm GB, Gofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 49: 103107.
  • 21
    Katz E, Mor E, Patel T, Theise N, Emre S, Schwartz ME, Miller CM. Association between preservation injury and early rejection in clinical liver transplantation: fact or myth? Transplant Proc 1993; 25: 19071908.
  • 22
    Swinnen LJ, Nordin-Costanzo MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizkies GJ, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990; 323: 17231728.
  • 23
    Hart J, Gonzales-Vallina R, Alonso E. A comparison of clinical outcome and histologic features in biopsies from cadaveric and living-related donor allografts [Abstract]. Mod Pathol 1994; 7: 62.